Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 45 M41 M41 M47 M48 M53 M 189 M Research & development 9 M9 M7 M8 M8 M9 M 32 M Operating income -13 M-5 M19 M-1 M-1 M15 M 32 M Non-Operating Income, Total 0-23 M1 M-150 M-8 M8 M -149 M Interest expense, net of interest capitalized 14 M15 M18 M15 M6 M6 M 45 M Non-Operating Income, excl. Interest Expenses -14 M-18 M-16 M-15 M-5 M-6 M -42 M Unusual income/expense 0-20 M-1 M-150 M-9 M8 M -152 M Pretax income -5 M-24 M16 M-99 M-13 M21 M -75 M Equity in earnings —————— — Taxes 2 M2 M3 M9 M3 M4 M 19 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -7 M-26 M13 M-108 M-16 M17 M -94 M Discontinued operations —————— — Net income -7 M-26 M13 M-108 M-16 M17 M -94 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -10 M-29 M-7 M-109 M-20 M13 M -123 M Basic earnings per share (Basic EPS) -0.12-0.36-0.08-1.22-0.210.13 -1.38 Diluted earnings per share (Diluted EPS) -0.12-0.36-0.08-1.22-0.210.13 -1.38 Average basic shares outstanding 80.6 M80.9 M89.8 M87 M97.5 M97.8 M — Diluted shares outstanding 80.6 M80.9 M89.8 M87 M97.5 M102.8 M — EBITDA -6 M-15 M23 M-8 M9 M21 M 45 M EBIT -13 M-22 M16 M-16 M2 M15 M 17 M Cost of revenue 201 M212 M201 M223 M208 M229 M 861 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 7 M7 M7 M8 M7 M6 M 28 M